Go
View All
[Z16.29] - Resistance to other single specified antibiotic
[Z16.3] - Resistance to other antimicrobial drugs
[Z16.30] - Resistance to unspecified antimicrobial drugs
[Z16.31] - Resistance to antiparasitic drug(s)
[Z16.32] - Resistance to antifungal drug(s)
[Z16.33] - Resistance to antiviral drug(s)
[Z16.34] - Resistance to antimycobacterial drug(s)
[Z16.341] - Resistance to single antimycobacterial drug
[Z16.342] - Resistance to multiple antimycobacterial drugs
[Z16.35] - Resistance to multiple antimicrobial drugs
[Z16.39] - Resistance to other specified antimicrobial drug
[Z16] - Resistance to antimicrobial drugs
[Z17.0] - Estrogen receptor positive status [ER+]
[Z17.1] - Estrogen receptor negative status [ER-]
[Z17.2] - Progesterone receptor status
[Z17.21] - Progesterone receptor positive status
[Z17.22] - Progesterone receptor negative status
[Z17.3] - Human epidermal growth factor 2 receptor
[Z17.31] - Human epidermal growth factor receptor 2 positive status
[Z17.32] - Human epidermal growth factor receptor 2 negative status
[Z17.4] - Combined receptor status
[Z17.41] - Hormone receptor positive
[Z17.410] - Hormone receptor positive with human epidermal growth factor receptor 2 positive status
[Z17.411] - Hormone receptor positive with human epidermal growth factor receptor 2 negative status
[Z17.42] - Hormone receptor negative
[Z17.420] - Hormone receptor negative with human epidermal growth factor receptor 2 positive status
[Z17.421] - Hormone receptor negative with human epidermal growth factor receptor 2 negative status
[Z17] - Estrogen, and other hormones and factors receptor status
[Z18.0] - Retained radioactive fragments
[Z18.01] - Retained depleted uranium fragments
Displaying items 48361 - 48390 of 50340